Search

Jan 19 // Taliaz selected by Deloitte as one of Digitial Trials

​14 Jan 2019 //

Taliaz selected by Deloitte as one of Digitial Trials - Israeli Startups at the forefront of the Digital R&D Revolution.

New report by Deloitte's Innovation Tech Terminal features Taliaz's breakthrough AI-driven personalized medicine solution helping assist the industry on the path to a digital transformation of clinical trials.


Read Report >






CONTACT US

Tel: +972 (0)77 335 2506

Fax: +972 (0)3 650 5594

office@taliazhealth.com

2 Prof. Yehezkel Kaufmann St.

(15th Floor), Tel Aviv-Yafo, Israel

  • LinkedIn
  • Twitter
  • Facebook
PREDICTIX_Logo_Dark.png

Disclaimer: Taliaz is developing the PREDICTIX Genetics and PREDICTIX Digital products. PREDICTIX Genetics Antidepressant and PREDICTIX Digital Antidepressant are currently available for commercial use in the EU and Israel. Outside of the EU and Israel, PREDICTIX Genetics & Digital products are currently limited by law for investigational use only.

Copyright © 2020 PREDICTIX by TALIAZ Ltd. All Rights Reserved